Does the media favor PRVA or HIMS?

In the previous week, Hims & Hers Health had 21 more articles in the media than Privia Health Group. MarketBeat recorded 23 mentions for Hims & Hers Health and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.06 beat Hims & Hers Health's score of 0.76 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 11 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PRVA or PACS?

In the previous week, PACS Group had 6 more articles in the media than Privia Health Group. MarketBeat recorded 8 mentions for PACS Group and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.06 beat PACS Group's score of -0.12 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor CAI or PRVA?

In the previous week, Caris Life Sciences had 3 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for Caris Life Sciences and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.06 beat Caris Life Sciences' score of 0.31 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Privia Health Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BLLN or PRVA?

In the previous week, Billiontoone had 3 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for Billiontoone and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.06 beat Billiontoone's score of -0.44 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Privia Health Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PRVA or SHC?

In the previous week, Privia Health Group had 1 more articles in the media than Sotera Health. MarketBeat recorded 2 mentions for Privia Health Group and 1 mentions for Sotera Health. Privia Health Group's average media sentiment score of 1.06 beat Sotera Health's score of 0.00 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Privia Health Group (PRVA) Competitors

$23.67 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$23.79 +0.12 (+0.50%)

As of 06/18/2026 05:02 PM Eastern

Compare

PRVA vs. HIMS, PACS, CAI, BLLN, and SHC

Should you buy Privia Health Group stock or one of its competitors? MarketBeat compares Privia Health Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Privia Health Group include Hims & Hers Health (HIMS), PACS Group (PACS), Caris Life Sciences (CAI), Billiontoone (BLLN), and Sotera Health (SHC). These companies are all part of the "healthcare" industry.

How does Privia Health Group compare to Hims & Hers Health?

Privia Health Group (NASDAQ:PRVA) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

In the previous week, Hims & Hers Health had 21 more articles in the media than Privia Health Group. MarketBeat recorded 23 mentions for Hims & Hers Health and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.06 beat Hims & Hers Health's score of 0.76 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	11 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Privia Health Group has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, meaning that its stock price is 137% more volatile than the broader market.

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Privia Health Group currently has a consensus price target of $31.15, indicating a potential upside of 31.62%. Hims & Hers Health has a consensus price target of $29.37, indicating a potential downside of 17.14%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts clearly believe Privia Health Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Hims & Hers Health	3 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.06

Privia Health Group has a net margin of 0.97% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	0.97%	2.81%	1.61%
Hims & Hers Health	-0.56%	6.10%	1.52%

Hims & Hers Health has higher revenue and earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.25B	1.33	$22.92M	$0.16	147.94
Hims & Hers Health	$2.35B	3.49	$128.37M	-$0.09	N/A

Summary

Privia Health Group beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to PACS Group?

Privia Health Group (NASDAQ:PRVA) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, valuation, dividends, risk and institutional ownership.

PACS Group has higher revenue and earnings than Privia Health Group. PACS Group is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.25B	1.33	$22.92M	$0.16	147.94
PACS Group	$5.29B	1.10	$191.54M	$1.56	23.51

In the previous week, PACS Group had 6 more articles in the media than Privia Health Group. MarketBeat recorded 8 mentions for PACS Group and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.06 beat PACS Group's score of -0.12 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Privia Health Group presently has a consensus target price of $31.15, suggesting a potential upside of 31.62%. PACS Group has a consensus target price of $48.00, suggesting a potential upside of 30.88%. Given Privia Health Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Privia Health Group is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

94.5% of Privia Health Group shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by insiders. Comparatively, 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

PACS Group has a net margin of 4.49% compared to Privia Health Group's net margin of 0.97%. PACS Group's return on equity of 26.47% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	0.97%	2.81%	1.61%
PACS Group	4.49%	26.47%	4.36%

Summary

PACS Group beats Privia Health Group on 8 of the 15 factors compared between the two stocks.

How does Privia Health Group compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

94.5% of Privia Health Group shares are held by institutional investors. 50.0% of Caris Life Sciences shares are held by company insiders. Comparatively, 5.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Caris Life Sciences presently has a consensus price target of $27.56, suggesting a potential upside of 49.19%. Privia Health Group has a consensus price target of $31.15, suggesting a potential upside of 31.62%. Given Caris Life Sciences' higher probable upside, equities research analysts clearly believe Caris Life Sciences is more favorable than Privia Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Caris Life Sciences has a net margin of 3.75% compared to Privia Health Group's net margin of 0.97%. Caris Life Sciences' return on equity of 98.28% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Privia Health Group	0.97%	2.81%	1.61%

Privia Health Group has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	6.43	-$68.09M	-$7.61	N/A
Privia Health Group	$2.25B	1.33	$22.92M	$0.16	147.94

In the previous week, Caris Life Sciences had 3 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for Caris Life Sciences and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.06 beat Caris Life Sciences' score of 0.31 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Privia Health Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Privia Health Group beats Caris Life Sciences on 8 of the 15 factors compared between the two stocks.

How does Privia Health Group compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership.

Privia Health Group has a net margin of 0.97% compared to Billiontoone's net margin of 0.00%. Privia Health Group's return on equity of 2.81% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Privia Health Group	0.97%	2.81%	1.61%

Billiontoone presently has a consensus target price of $125.29, suggesting a potential upside of 19.15%. Privia Health Group has a consensus target price of $31.15, suggesting a potential upside of 31.62%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts clearly believe Privia Health Group is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

94.5% of Privia Health Group shares are held by institutional investors. 5.7% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Billiontoone had 3 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for Billiontoone and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.06 beat Billiontoone's score of -0.44 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Privia Health Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Privia Health Group has higher revenue and earnings than Billiontoone. Privia Health Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	15.85	$7.45M	$0.55	191.18
Privia Health Group	$2.25B	1.33	$22.92M	$0.16	147.94

Summary

Privia Health Group beats Billiontoone on 11 of the 15 factors compared between the two stocks.

How does Privia Health Group compare to Sotera Health?

Privia Health Group (NASDAQ:PRVA) and Sotera Health (NASDAQ:SHC) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

Sotera Health has a net margin of 9.91% compared to Privia Health Group's net margin of 0.97%. Sotera Health's return on equity of 39.73% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	0.97%	2.81%	1.61%
Sotera Health	9.91%	39.73%	7.05%

In the previous week, Privia Health Group had 1 more articles in the media than Sotera Health. MarketBeat recorded 2 mentions for Privia Health Group and 1 mentions for Sotera Health. Privia Health Group's average media sentiment score of 1.06 beat Sotera Health's score of 0.00 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sotera Health has lower revenue, but higher earnings than Privia Health Group. Sotera Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.25B	1.33	$22.92M	$0.16	147.94
Sotera Health	$1.16B	3.88	$77.94M	$0.41	38.59

94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 5.7% of Privia Health Group shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Privia Health Group has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, Sotera Health has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market.

Privia Health Group presently has a consensus target price of $31.15, indicating a potential upside of 31.62%. Sotera Health has a consensus target price of $20.29, indicating a potential upside of 28.23%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts clearly believe Privia Health Group is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

Privia Health Group and Sotera Health tied by winning 8 of the 16 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRVA vs. The Competition

Export

Metric	Privia Health Group	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.98B	$1.58B	$6.42B	$12.59B
Dividend Yield	N/A	N/A	2.68%	5.81%
P/E Ratio	147.95	77.84	24.78	24.44
Price / Sales	1.33	7.55	532.71	109.74
Price / Cash	88.69	23.77	45.07	55.09
Price / Book	3.68	5.12	10.80	6.58
Net Income	$22.92M	-$54.76M	$3.57B	$337.17M
7 Day Performance	1.02%	3.27%	0.72%	0.83%
1 Month Performance	4.55%	-2.04%	0.41%	2.25%
1 Year Performance	8.33%	-0.52%	29.34%	36.14%

Privia Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRVA Privia Health Group	4.344 of 5 stars	$23.67 flat	$31.15 +31.6%	+8.3%	$2.98B	$2.25B	147.95	1,226	Positive News High Trading Volume
HIMS Hims & Hers Health	3.0215 of 5 stars	$31.69 +5.0%	$28.70 -9.4%	-45.0%	$7.33B	$2.35B	N/A	2,442	Analyst Forecast Insider Trade
PACS PACS Group	3.7915 of 5 stars	$35.79 -1.3%	$48.00 +34.1%	+176.8%	$5.66B	$5.29B	22.94	47,455	News Coverage Insider Trade Gap Up
CAI Caris Life Sciences	4.3745 of 5 stars	$18.38 +1.1%	$27.56 +49.9%	N/A	$5.20B	$812.03M	N/A	1,846
BLLN Billiontoone	3.2796 of 5 stars	$103.03 -0.9%	$125.29 +21.6%	N/A	$4.74B	$305.11M	187.32	620	News Coverage Insider Trade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRVA) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Privia Health Group (PRVA) Competitors

PRVA vs. HIMS, PACS, CAI, BLLN, and SHC

How does Privia Health Group compare to Hims & Hers Health?

Summary

How does Privia Health Group compare to PACS Group?

Summary

How does Privia Health Group compare to Caris Life Sciences?

Summary

How does Privia Health Group compare to Billiontoone?

Summary

How does Privia Health Group compare to Sotera Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Privia Health Group (PRVA) Competitors

PRVA vs. HIMS, PACS, CAI, BLLN, and SHC

How does Privia Health Group compare to Hims & Hers Health?

Does the media favor PRVA or HIMS?

Which has more risk and volatility, PRVA or HIMS?

Do insiders & institutionals have more ownership in PRVA or HIMS?

Do analysts prefer PRVA or HIMS?

Is PRVA or HIMS more profitable?

Which has better valuation and earnings, PRVA or HIMS?

Summary

How does Privia Health Group compare to PACS Group?

Which has higher earnings & valuation, PRVA or PACS?

Does the media favor PRVA or PACS?

Do analysts prefer PRVA or PACS?

Do insiders and institutionals have more ownership in PRVA or PACS?

Is PRVA or PACS more profitable?

Summary

How does Privia Health Group compare to Caris Life Sciences?

Do institutionals & insiders hold more shares of CAI or PRVA?

Do analysts recommend CAI or PRVA?

Is CAI or PRVA more profitable?

Which has stronger valuation and earnings, CAI or PRVA?

Does the media favor CAI or PRVA?

Summary

How does Privia Health Group compare to Billiontoone?

Is BLLN or PRVA more profitable?

Do analysts prefer BLLN or PRVA?

Do institutionals and insiders have more ownership in BLLN or PRVA?

Does the media prefer BLLN or PRVA?

Which has stronger earnings and valuation, BLLN or PRVA?

Summary

How does Privia Health Group compare to Sotera Health?

Is PRVA or SHC more profitable?

Does the media favor PRVA or SHC?

Which has preferable valuation & earnings, PRVA or SHC?

Do insiders and institutionals believe in PRVA or SHC?

Which has more volatility and risk, PRVA or SHC?

Do analysts prefer PRVA or SHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools